ESMO 2019: Advances in Treating Ovarian Cancer, Lung Cancer, and TRK Protein Mutations

Language English

November 14, 2019

gregguthrie

Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment.

from Cancer.Net Blog https://ift.tt/2qOzQYi